U-Factor Life Science

Beijing U-Factor Life Science Co., Ltd. is a clinical-stage biotechnology company specializing in the development of next-generation cell therapies and regenerative medicine. The company focuses on the research and industrialization of Natural Killer (NK) cell-based immunotherapies and mesenchymal stem cell (MSC) technologies. Utilizing its proprietary U-NK platform, U-Factor enables the large-scale expansion and activation of high-purity, off-the-shelf NK cells for oncology applications. Their pipeline includes CAR-NK candidates targeting solid tumors and hematological malignancies, alongside MSC-based treatments for chronic degenerative diseases. U-Factor is positioned as a leader in the Chinese cellular immunotherapy sector, integrating advanced genetic engineering with robust manufacturing capabilities.